Phase I Dose Escalation Study of AB-16B5 in Subjects With an Advanced Solid Malignancy

NCT02412462 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
15
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Alethia Biotherapeutics